CD8A and ovarian carcinoma: The density of these CD8+CD103+T cells has been linked to improved overall clinical outcomes across various epithelial tumors, including lung cancer [19], ovarian carcinoma [18], breast cancer [21], endometrial adenocarcinoma [22], urothelial cell carcinoma of the bladder [20], and HPV‐induced cervical cancer [23].